Your browser doesn't support javascript.
loading
The role of immune checkpoint receptors in the malignant phenotype of cutaneous T cell lymphoma.
Shreberk-Hassidim, Rony; Geiger-Maor, Anat; Eisenberg, Galit; Merims, Sharon; Hajaj, Emma; Cohen, Jonathan E; Klein, Shiri; Frankenburg, Shoshana; Moyal, Lilach; Hodak, Emilia; Zlotogorski, Abraham; Lotem, Michal.
Afiliação
  • Shreberk-Hassidim R; Department of Dermatology, The Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel. rshreberk@gmail.com.
  • Geiger-Maor A; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Eisenberg G; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Merims S; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hajaj E; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Cohen JE; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Klein S; The Wohl Institute for Translational Medicine, Hadassah Medical Center, Jerusalem, Israel.
  • Frankenburg S; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Moyal L; The Faculty of Medicine, Sharett Institute of Oncology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Hodak E; Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
  • Zlotogorski A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Lotem M; Department of Dermatology, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.
Immunol Res ; 70(6): 793-799, 2022 12.
Article em En | MEDLINE | ID: mdl-35867216

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Receptor de Morte Celular Programada 1 Limite: Humans Idioma: En Revista: Immunol Res Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Cutâneo de Células T / Receptor de Morte Celular Programada 1 Limite: Humans Idioma: En Revista: Immunol Res Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel